Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects

Science Communicator Platform

Share By

Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects Publisher Pubmed

Barati M^{1, 2} ; Sinaeian M³ ; Shokrollahi Barough M^{4, 5} ; Pak F⁶ ; Semnani V⁷ ; Kokhaei P^{6, 8, 9} ; Momtaziborojeni AA^{10, 11, 12}

Source: Journal of Interferon and Cytokine Research Published:2020

Abstract

Color images are available online. Interleukin 25 (IL-25) is a ligand for IL-25 receptor (IL-25R) with apoptotic effect on breast cancer epithelial cells that are produced by peripheral blood mononuclear cells (PBMCs). In this study, we aimed to evaluate IL-25/IL-25R mRNA expression in PBMCs, and also investigate correlation of IL-25/IL-25R with tumor stages/grades in patients with breast cancer. PBMCs and serum were isolated from 30 patients with breast cancer and 18 normal subjects. ELISA test was conducted for IL-25 cytokine. Total RNA was isolated from 2 × 106 PBMCs and reverse transcribed to cDNA. Quantitative PCRs were performed for IL-25, IL-25R, and GAPDH genes. IL-25 mRNA expression in PBMCs of breast cancer patients (malignant and benign) was significantly lower than that in normal subjects, Also IL-25 expression in breast cancer patients with malignant tumor was significantly lower than that in nonmalignant patients. IL-25R expression in malignant patients was significantly higher than that of benign and normal subjects (P < 0.05). IL-25 in serum of normal subjects was higher than that of benign and malignant patients. There was a direct association between IL-25R expression and tumor grade/stage of cancer. In conclusion, IL-25 seems as a potential prognostic factor in the serum of breast cancer patients and reduction of IL-25 is associated with a higher grade/stage of cancer. © Mary Ann Liebert, Inc., publishers 2020.

Related Docs

View other Related Docs

1. Distinctive Expression Pattern of Interleukin-17 Cytokine Family Members in Colorectal Cancer, Tumor Biology (2016)

2. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)

3. Identification and Validation of Stage-Associated Pbmc Biomarkers in Breast Cancer Using Ms-Based Proteomics, Frontiers in Oncology (2020)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (2)

Habibollah Mahmoodzadeh (2)

Other Related Docs

4. Il-17 and Colorectal Cancer: From Carcinogenesis to Treatment, Cytokine (2019)

5. Study of the Tumor Microenvironment During Breast Cancer Progression, Cancer Cell International (2017)

6. Molecular Mechanisms of Curcumins Suppressing Effects on Tumorigenesis, Angiogenesis and Metastasis, Focusing on Nf-Κb Pathway, Cytokine and Growth Factor Reviews (2016)

7. Isolation and Characterization of the Primary Epithelial Breast Cancer Cells and the Adjacent Normal Epithelial Cells From Iranian Women’S Breast Cancer Tumors, Cytotechnology (2018)

8. Il-25 Impact on Malignant B Cells Survival and T Cells Activation in Chronic Lymphocytic Leukemia, Iranian Journal of Allergy# Asthma and Immunology (2023)

9. Prognostic Role of the Systemic Immune–Inflammation Index in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy: Results From a Large Multicenter International Collaboration, Cancer Immunology# Immunotherapy (2021)

10. Association of Kir Genes and Their Hla Ligands Diversity With Colorectal Cancer in Lur Population of Iran, Meta Gene (2019)

11. Dysregulated Expression of Mir-146A and Its Associated Immune Effectors in Peripheral Blood Mononuclear Cells of Esophageal Carcinoma Patients, Immunological Investigations (2022)

12. Gene Expression Profiles of Cyp24a1 and Cyp27b1 in Malignant and Normal Breast Tissues, Molecular Medicine Reports (2017)

13. Concomitant Overexpression of Mir-182-5P and Mir-182-3P Raises the Possibility of Il-17–Producing Treg Formation in Breast Cancer by Targeting Cd3d, Itk, Foxo1, and Nfats: A Meta-Analysis and Experimental Study, Cancer Science (2021)

14. The Expression Levels of Circulating Mir-129 and Mir-203A in Association With Breast Cancer and Related Metastasis, Iranian Journal of Public Health (2022)

15. An Innovative Systematic Approach Introduced the Involved Lncrna-Mir-Mrna Network in Cell Cycle and Proliferation After Conventional Treatments in Breast Cancer Patients, Cell Cycle (2022)

16. Subtype-Specific Expression of Lncrnas Snhg12 and Haglr As Non-Invasive Biomarkers for Diagnosis and Prognosis in Breast Cancer, Irish Journal of Medical Science (2025)

17. Down-Regulated Microrna-124 Expression As Predictive Biomarker and Its Prognostic Significance With Clinicopathological Features in Breast Cancer Patients, Diagnostic Pathology (2015)

18. Evaluating the Mechanism Underlying Antitumor Effect of Interleukin 27 on B Cells of Chronic Lymphocytic Leukemia Patients, Journal of Cellular Physiology (2020)

19. Characterization of Immune Checkpoints Expression and Lymphocyte Densities of Iranian Breast Cancer Patients; the Co-Expression Status and Clinicopathological Associates, BMC Cancer (2023)

20. Dietary Inflammatory Potential Score and Risk of Breast Cancer: Systematic Review and Meta-Analysis, Clinical Breast Cancer (2018)

Style	Citing Format
MLA	Barati M, et al.. "Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects." Journal of Interferon and Cytokine Research, vol. 40, no. 3, 2020, pp. 139-144.
APA	Barati M, Sinaeian M, Shokrollahi Barough M, Pak F, Semnani V, Kokhaei P, Momtaziborojeni AA (2020). Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects. Journal of Interferon and Cytokine Research, 40(3), 139-144.
Chicago	Barati M, Sinaeian M, Shokrollahi Barough M, Pak F, Semnani V, Kokhaei P, Momtaziborojeni AA. "Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects." Journal of Interferon and Cytokine Research 40, no. 3 (2020): 139-144.
Harvard	Barati M et al. (2020) 'Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects', Journal of Interferon and Cytokine Research, 40(3), pp. 139-144.
Vancouver	Barati M, Sinaeian M, Shokrollahi Barough M, Pak F, Semnani V, Kokhaei P, et al.. Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects. Journal of Interferon and Cytokine Research. 2020;40(3):139-144.
BibTex	@article{ author = {Barati M and Sinaeian M and Shokrollahi Barough M and Pak F and Semnani V and Kokhaei P and Momtaziborojeni AA}, title = {Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects}, journal = {Journal of Interferon and Cytokine Research}, volume = {40}, number = {3}, pages = {139-144}, year = {2020} }
RIS	TY - JOUR AU - Barati M AU - Sinaeian M AU - Shokrollahi Barough M AU - Pak F AU - Semnani V AU - Kokhaei P AU - Momtaziborojeni AA TI - Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects JO - Journal of Interferon and Cytokine Research VL - 40 IS - 3 SP - 139 EP - 144 PY - 2020 ER -

Science Communicator Platform

Authors

Abstract